IgA vasculitis (Henoch-Shonlein purpura) in adults: Diagnostic and therapeutic aspects

被引:185
作者
Audemard-Verger, Alexandra [1 ]
Pillebout, Evangeline [2 ]
Guillevin, Loic [1 ]
Thervet, Eric [3 ]
Terrier, Benjamin [1 ]
机构
[1] Univ Paris 05, Natl Referral Ctr Rare Syst Autoimmune Dis, Hop Cochin, AP HP,Dept Internal Med, Paris, France
[2] Hop St Louis, AP HP, Dept Nephrol, Paris, France
[3] Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Dept Nephrol, Paris, France
关键词
IgA vasculitis; Henoch-Shonlein purpura; Characteristics; Prognosis; Treatment; SCHONLEIN PURPURA; NEPHRITIS; CHILDREN; COLCHICINE; RITUXIMAB; DAPSONE; NEPHROPATHY; PREDNISONE; DISEASE; CYCLOPHOSPHAMIDE;
D O I
10.1016/j.autrev.2015.02.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immunoglobulin A (IgA) vasculitis, formerly called Henoch-Schonlein purpura, is an immune complex vasculitis affecting small vessels with dominant IgA deposits. Clinical manifestations mainly involve cutaneous purpura, arthralgias and/or arthritis, acute enteritis and glomerulonephritis. IgA vasculitis is more common among children than adults, with more severe disease in adults. Gastrointestinal and renal involvements represent the principal causes of morbidity and mortality in adults. Factors associated with long-term end-stage renal disease (ESRD) include baseline renal function impairment and baseline proteinuria >1 or 15 g/day, and on renal biopsy degree of interstitial fibrosis, sclerotic glomeruli and fibrinoid necrosis. Management of IgA vasculitis in adults is rendered difficult for clinicians because of the absence of correlation between initial presentation and long-term renal outcome, and the possible occurrence of spontaneous remission in patients with severe presentation or, in contrast, possible evolution to ESRD in patients with mild symptoms. Treatment is often symptomatic because disease course is usually benign. Treatment of severe involvement, including severe gastrointestinal complications or proliferative glomerulonephritis, remains controversial, with no evidence that corticosteroids or immunosuppressive agents improved long-term outcome. Prospective, randomized, controlled trials are thus needed to analyze the benefit-risk ratio of suth treatments. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:579 / 585
页数:7
相关论文
共 65 条
[1]   Addition of Plasma Exchange to Glucocorticosteroids for the Treatment of Severe Henoch-Schonlein Purpura in Adults: A Case Series [J].
Augusto, Jean-Francois ;
Sayegh, Johnny ;
Delapierre, Laurence ;
Croue, Anne ;
Tollis, Frederic ;
Cousin, Maud ;
Subra, Jean-Francois .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2012, 59 (05) :663-669
[2]   MICROTUBULES IN PMNS FROM PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER [J].
BARELI, M ;
WILSON, L ;
PETERS, RS ;
SCHWABE, AD ;
TERRITO, MC .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1982, 284 (02) :2-7
[3]  
Bech AP, 2013, NETH J MED, V71, P220
[4]  
Bergstein J, 1998, CLIN NEPHROL, V49, P9
[5]   Henoch-Schonlein purpura in adulthood and childhood - Two different expressions of the same syndrome [J].
Blanco, R ;
MartinezTaboada, VM ;
RodriguezValverde, V ;
GarciaFuentes, M ;
GonzalezGay, MA .
ARTHRITIS AND RHEUMATISM, 1997, 40 (05) :859-864
[6]   COLCHICINE IS EFFECTIVE IN CONTROLLING CHRONIC CUTANEOUS LEUKOCYTOCLASTIC VASCULITIS [J].
CALLEN, JP .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1985, 13 (02) :193-200
[7]   Henoch-Schonlein Purpura in Northern Spain Clinical Spectrum of the Disease in 417 Patients From a Single Center [J].
Calvo-Rio, Vanesa ;
Loricera, Javier ;
Mata, Cristina ;
Martin, Luis ;
Ortiz-Sanjuan, Francisco ;
Alvarez, Lino ;
Gonzalez-Vela, M. Carmen ;
Gonzalez-Lamuno, Domingo ;
Rueda-Gotor, Javier ;
Fernandez-Llaca, Hector ;
Gonzalez-Lopez, Marcos A. ;
Armesto, Susana ;
Peiro, Enriqueta ;
Arias, Manuel ;
Gonzalez-Gay, Miguel A. ;
Blanco, Ricardo .
MEDICINE, 2014, 93 (02) :106-113
[8]  
Chartapisak W, 2009, COCHRANE DB SYST REV, V3
[9]   Long-term prognosis of Henoch-Schonlein nephritis in adults and children [J].
Coppo, R ;
Mazzucco, G ;
Cagnoli, L ;
Lupo, A ;
Schena, FP .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (11) :2277-2283
[10]   Henoch-Schonlein Purpura Nephritis: Pathophysiology, Treatment, and Future Strategy [J].
Davin, Jean-Claude .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (03) :679-689